| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.12.25 | MEDI&GENE Enters Catalyze Agreement with Lilly to Advance Obesity Therapeutic | ||
| 16.12.25 | Takeda Joins BaseLaunch Biotech Venture Incubator | ||
| 16.12.25 | TreeFrog Therapeutics Names Mark Rothera as CEO | ||
| 16.12.25 | ADEL Enters Global License Agreement with Sanofi for ADEL-Y01 | ||
| 16.12.25 | Lindus Health, Quotient Sciences Partner to Accelerate Drug Development to Clinical Trials | ||
| 16.12.25 | Leadership Changes at NorthStar Medical Radioisotopes | ||
| 16.12.25 | EMA Approves Grifols Egypt's Full Plasma Value Chain | ||
| 15.12.25 | Thermo Fisher Expands Gibco Bacto CD Portfolio with New E. coli Media | ||
| 15.12.25 | Dren Bio Expands Strategic Collaboration with Sanofi | ||
| 15.12.25 | Gaelic Laboratories Acquires Athlone Laboratories | ||
| 15.12.25 | SOBI Agrees to Acquire Arthrosi Therapeutics | ||
| 12.12.25 | Zealand Pharma, OTR Therapeutics Sign Deal to Develop Metabolic Disease Treatments | ||
| 12.12.25 | Lilly to Invest $6B in New API Manufacturing Facility in Alabama | ||
| 11.12.25 | Developer of 'Physical AI Scientists' Raises $52M | ||
| 11.12.25 | Charles River Announces Latest Cohort of Its Cell & Gene Therapy Incubator Program | ||
| 10.12.25 | Cytiva, Fidabio Partner to Expand Analytical Capabilities for Protein Research | ||
| 10.12.25 | The Wellcome Sanger Institute Selects Sapio Informatics as Its Central LIMS | ||
| 10.12.25 | Advarra Expands Its Network of Partner Applications | ||
| 10.12.25 | Tjoapack Invests in New 170,000-Square-Foot Facility in Tennessee | ||
| 10.12.25 | Expression Therapeutics Taps Former Pfizer, Novartis Exec as CEO | ||
| 10.12.25 | Zydus & Formycon Partner for Keytruda Biosimilar in US & Canada | ||
| 09.12.25 | Bora Pharmaceuticals, Corealis Pharma Partner to Provide End-to-End Services | ||
| 09.12.25 | Ability Biotherapeutics Appoints Dr. Angele Maki as Chief Business Officer | ||
| 09.12.25 | Marchesini Group, AST Partner to Expand Capacity and Global Network | ||
| 09.12.25 | ProBioGen, Spica Therapeutics Partner to Advance ST101 |